HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

Published on Jan 24, 2015in The Lancet60.392
· DOI :10.1016/S0140-6736(14)61183-1
Daniel I. Swerdlow21
Estimated H-index: 21
(UCL: University College London),
David Preiss48
Estimated H-index: 48
(Glas.: University of Glasgow)
+ 130 AuthorsNaveed Sattar172
Estimated H-index: 172
(Glas.: University of Glasgow)
Summary Background Statins increase the risk of new-onset type 2 diabetes mellitus. We aimed to assess whether this increase in risk is a consequence of inhibition of 3-hydroxy-3-methylglutaryl-C oA reductase (HMGCR), the intended drug target. Methods We used single nucleotide polymorphisms in the HMGCR gene, rs17238484 ( for the main analysis) and rs12916 (for a subsidiary analysis) as proxies for HMGCR inhibition by statins. We examined associations of these variants with plasma lipid, glucose, and insulin concentrations; bodyweight; waist circumference; and prevalent and incident type 2 diabetes. Study-specifi c eff ect estimates per copy of each LDL-lowering allele were pooled by metaanalysis. These fi ndings were compared with a meta-analysis of new-onset type 2 diabetes and bodyweight change data from randomised trials of statin drugs. The eff ects of statins in each randomised trial were assessed using meta-analysis. Findings Data were available for up to 223 463 individuals from 43 genetic studies. Each additional rs17238484-G allele was associated with a mean 0·06 mmol/L (95% CI 0·05–0·07) lower LDL cholesterol and higher body weight (0·30 kg, 0·18–0·43), waist circumference (0·32 cm, 0·16–0·47), plasma insulin concentration (1·62%, 0·53–2·72), and plasma glucose concentration (0·23%, 0·02–0·44). The rs12916 SNP had similar eff ects on LDL cholesterol, bodyweight, and waist circumference. The rs17238484-G allele seemed to be associated with higher risk of type 2 diabetes (odds ratio [OR] per allele 1·02, 95% CI 1·00–1·05); the rs12916-T allele association was consistent (1·06, 1·03–1·09). In 129 170 individuals in randomised trials, statins lowered LDL cholesterol by 0·92 mmol/L (95% CI 0·18–1·67) at 1-year of follow-up, increased bodyweight by 0·24 kg (95% CI 0·10–0·38 in all trials; 0·33 kg, 95% CI 0·24–0·42 in placebo or standard care controlled trials and –0·15 kg, 95% CI –0·39 to 0·08 in intensive-dose vs moderate-dose trials) at a mean of 4·2 years (range 1·9–6·7) of follow-up, and increased the odds of new-onset type 2 diabetes (OR 1·12, 95% CI 1·06–1·18 in all trials; 1·11, 95% CI 1·03–1·20 in placebo or standard care controlled trials and 1·12, 95% CI 1·04–1·22 in intensive-dose vs moderate dose trials).
📖 Papers frequently viewed together
241 Citations
18 Authors (David Preiss, ..., Kausik K. Ray)
1,005 Citations
16 Authors (Neil J. Stone, ..., Peter Wilson)
3,395 Citations
#1Michael J. Pencina (Duke University)H-Index: 107
Last. Eric D. Peterson (Duke University)H-Index: 3
view all 7 authors...
Background The 2013 guidelines of the American College of Cardiology and the American Heart Association (ACC–AHA) for the treatment of cholesterol expand the indications for statin therapy for the prevention of cardiovascular disease. Methods Using data from the National Health and Nutrition Examination Surveys of 2005 to 2010, we estimated the number, and summarized the risk-factor profile, of persons for whom statin therapy would be recommended (i.e., eligible persons) under the new ACC–AHA gu...
495 CitationsSource
#1Michael V. Holmes (UCL: University College London)H-Index: 52
#2Leslie A. Lange (UNC: University of North Carolina at Chapel Hill)H-Index: 72
Last. Brendan J. Keating (UPenn: University of Pennsylvania)H-Index: 56
view all 34 authors...
Elevated body mass index (BMI) associates with cardiometabolic traits on observational analysis, yet the underlying causal relationships remain unclear. We conducted Mendelian randomization analyses by using a genetic score (GS) comprising 14 BMI-associated SNPs from a recent discovery analysis to investigate the causal role of BMI in cardiometabolic traits and events. We used eight population-based cohorts, including 34,538 European-descent individuals (4,407 type 2 diabetes (T2D), 6,073 corona...
165 CitationsSource
#1Ron Do (Broad Institute)H-Index: 44
#2Cristen J. Willer (UM: University of Michigan)H-Index: 78
Last. Sekar Kathiresan (Broad Institute)H-Index: 137
view all 262 authors...
Triglycerides are transported in plasma by specific triglyceride-rich lipoproteins; in epidemiological studies, increased triglyceride levels correlate with higher risk for coronary artery disease (CAD). However, it is unclear whether this association reflects causal processes. We used 185 common variants recently mapped for plasma lipids (P < 5 x 10(-8) for each) to examine the role of triglycerides in risk for CAD. First, we highlight loci associated with both low-density lipoprotein cholester...
628 CitationsSource
#1Cristen J. Willer (UM: University of Michigan)H-Index: 78
#2Ellen M. Schmidt (UM: University of Michigan)H-Index: 22
Last. Gonçalo R. Abecasis (UM: University of Michigan)H-Index: 180
view all 258 authors...
Levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides and total cholesterol are heritable, modifiable risk factors for coronary artery disease. To identify new loci and refine known loci influencing these lipids, we examined 188,577 individuals using genome-wide and custom genotyping arrays. We identify and annotate 157 loci associated with lipid levels at P < 5 x 10(-8), including 62 loci not previously associated with lipid levels in hum...
1,904 CitationsSource
#1Aleesa A Carter (TGH: Toronto General Hospital)H-Index: 1
#2Tara Gomes (St. Michael's Hospital)H-Index: 46
Last. Muhammad MamdaniH-Index: 91
view all 6 authors...
Objective To examine the risk of new onset diabetes among patients treated with different HMG-CoA reductase inhibitors (statins). Design Population based cohort study with time to event analyses to estimate the relation between use of particular statins and incident diabetes. Hazard ratios were calculated to determine the effect of dose and type of statin on the risk of incident diabetes. Setting Ontario, Canada. Participants All patients aged 66 or older without diabetes who started treatment w...
291 CitationsSource
#1Goodarz Danaei (Harvard University)H-Index: 56
Last. Miguel A. Hernán (MIT: Massachusetts Institute of Technology)H-Index: 107
view all 4 authors...
OBJECTIVE Two meta-analyses of randomized trials of statins found increased risk of type 2 diabetes. One possible explanation is bias due to differential survival when patients who are at higher risk of diabetes survive longer under statin treatment. RESEARCH DESIGN AND METHODS We used electronic medical records from 500 general practices in the U.K. and included data from 285,864 men and women aged 50–84 years from January 2000 to December 2010. We emulated the design and analysis of a hypothet...
49 CitationsSource
#1Eliano Pio Navarese (UMK: Nicolaus Copernicus University in Toruń)H-Index: 34
#2Antonino Buffon (UCSC: Catholic University of the Sacred Heart)H-Index: 26
Last. Jacek Kubica (UMK: Nicolaus Copernicus University in Toruń)H-Index: 30
view all 14 authors...
Recent reports indicate that statins are associated with an increased risk for new-onset diabetes mellitus (DM) compared with placebo and that this relation is dose dependent. The aim of this study was to perform a comprehensive network meta-analysis of randomized controlled trials (RCTs) investigating the impact of different types and doses of statins on new-onset DM. RCTs comparing different types and doses of statins with placebo were searched for using the MEDLINE, Embase, and Cochrane datab...
186 CitationsSource
#1Kelly Axsom (NYU: New York University)H-Index: 2
#2Jeffrey S. Berger (NYU: New York University)H-Index: 59
Last. Arthur Schwartzbard (NYU: New York University)H-Index: 16
view all 3 authors...
The ability for statins to reduce major cardiovascular events and mortality has lead to this drug class being the most commonly prescribed in the world. In particular, the benefit of these drugs in type 2 diabetes (T2D) is well established. In February 2012, the Food and Drug Administration released changes to statin safety label to include that statins have been associated with increases in hemoglobin A1C and fasting serum glucose levels. This has stirred much debate in the medical community. E...
24 CitationsSource
#1Andrew P. Morris (University of Oxford)H-Index: 106
#2Benjamin F. Voight (UPenn: University of Pennsylvania)H-Index: 80
Last. Mark I. McCarthy (University of Oxford)H-Index: 200
view all 204 authors...
To extend understanding of the genetic architecture and molecular basis of type 2 diabetes (T2D), we conducted a meta-analysis of genetic variants on the Metabochip, including 34,840 cases and 114,981 controls, overwhelmingly of European descent. We identified ten previously unreported T2D susceptibility loci, including two showing sex-differentiated association. Genome-wide analyses of these data are consistent with a long tail of additional common variant loci explaining much of the variation ...
1,547 CitationsSource
#1Robert A. ScottH-Index: 106
#2Vasiliki Lagou (University of Oxford)H-Index: 6
Last. Inês Barroso (University of Cambridge)H-Index: 109
view all 214 authors...
Through genome-wide association meta-analyses of up to 133,010 individuals of European ancestry without diabetes, including individuals newly genotyped using the Metabochip, we have increased the number of confirmed loci influencing glycemic traits to 53, of which 33 also increase type 2 diabetes risk (q < 0.05). Loci influencing fasting insulin concentration showed association with lipid levels and fat distribution, suggesting impact on insulin resistance. Gene-based analyses identified further...
632 CitationsSource
Cited By421
#1Lucie Dlouhá (Charles University in Prague)H-Index: 1
#2Terezie PelikanovaH-Index: 17
Last. Jaroslav A. Hubacek (Charles University in Prague)H-Index: 41
view all 9 authors...
BACKGROUND Common polymorphisms within the apolipoprotein E (APOE) gene are suggested to be associated with the development of type 2 diabetes mellitus (T2DM), but the potential association with T2DM complications (nephropathy, neuropathy and retinopathy) remains unclear. We perform the case-control study to analyse the association between the APOE polymorphism and risk of T2DM and to analysed the potential relationship between the APOE and T2DM complications. METHODS AND RESULTS APOE variants (...
#1Sara Sokooti (UMCG: University Medical Center Groningen)H-Index: 1
#2Jose L Flores-Guerrero (UMCG: University Medical Center Groningen)H-Index: 6
Last. Robin P. F. Dullaart (UMCG: University Medical Center Groningen)H-Index: 69
view all 6 authors...
Background null Triglyceride-rich lipoproteins particles (TRLP) and low density lipoprotein particles (LDLP) vary in size. Their association with β-cell function is not well described. We determined associations of TRLP and LDLP subfractions with β-cell function, estimated as HOMA-β, and evaluated their associations with incident T2D in the general population. null Methods null We included 4818 subjects of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) study without T2D at base...
#1Yuhao Liu (UM: University of Michigan)H-Index: 4
#2Ying Zhao (UM: University of Michigan)H-Index: 2
Last. Guizhen Zhao (UM: University of Michigan)H-Index: 3
view all 25 authors...
Dysregulated glycine metabolism is emerging as a common denominator in cardiometabolic diseases, but its contribution to atherosclerosis remains unclear. In this study, we demonstrate impaired glycine-oxalate metabolism through alanine-glyoxylate aminotransferase (AGXT) in atherosclerosis. As found in patients with atherosclerosis, the glycine/oxalate ratio is decreased in atherosclerotic mice concomitant with suppression of AGXT. Agxt deletion in apolipoprotein E-deficient (Apoe-/-) mice decrea...
#1Eva Xepapadaki (RMIT: RMIT University)H-Index: 7
#2Ioanna Nikdima (RMIT: RMIT University)
Last. Kyriakos E. Kypreos (RMIT: RMIT University)H-Index: 28
view all 5 authors...
HDL is a complex macromolecular cluster of various components, such as apolipoproteins, enzymes and lipids. Quality evidence from clinical and epidemiological studies led to the principle that HDL-cholesterol (HDL-C) levels are inversely correlated with the risk of CHD. Nevertheless, the failure of many cholesteryl ester transfer protein inhibitors to protect against CVD casts doubts on this principle and highlights the fact that HDL functionality, as dictated by its proteome and lipidome, also ...
#1Camelia C. Diaconu (AHEPA University Hospital)
Last. Manfredi RizzoH-Index: 64
view all 6 authors...
PURPOSE OF REVIEW Hypercholesterolemia is a major risk factor for cardiovascular diseases. Administration of statins represents the cornerstone of the prevention and treatment of cardiovascular disease, with demonstrated long-term safety and efficacy. This review aims to revisit statin intolerance mechanisms, as well as to discuss new data and therapeutic options. RECENT FINDINGS Although statins are well tolerated, myopathy and other adverse effects are a challenging problem, being the main rea...
3 CitationsSource
#1Shun Li (Li Ka Shing Faculty of Medicine, University of Hong Kong)H-Index: 1
#2Catherine Mary Schooling (Li Ka Shing Faculty of Medicine, University of Hong Kong)H-Index: 20
Background null Beyond their success in cardiovascular disease prevention, statins are increasingly recognized to have sex-specific pleiotropic effects. To gain additional insight, we characterized associations of genetically mimicked statins across the phenotype sex-specifically. We also assessed whether any apparently non-lipid effects identified extended to genetically mimicking other widely used lipid modifiers (proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and ezetimibe) ...
Diabetes mellitus is a public health problem. The study used systematic literature reviews (SLR), which is a synthesis of a systematic literature study that is clear, comprehensive, by identifying, analyzing, evaluating through the collection of existing data with an explicit search method and involving the processes that have been critical in the selection of studies. The results found that 20 relevant articles have been reviewed and showed most of the evidence was significant on reducing fasti...
Alterations in lipid metabolism within beta cells and islets contributes to dysfunction and apoptosis of beta cells, leading to loss of insulin secretion and the onset of type 2 diabetes. Over the last decade, there has been an explosion of interest in understanding the landscape of gene expression which influences beta cell function, including the importance of small non-coding microRNA sequences in this context. This review sought to identify the microRNA sequences regulated by metabolic chall...
Non-alcoholic fatty liver disease (NAFLD) is a quickly emerging global health problem representing the most common chronic liver disease in the world. Atherosclerotic cardiovascular disease represents the leading cause of mortality in NAFLD patients. Cholesterol metabolism has a crucial role in the pathogenesis of both NAFLD and atherosclerosis. The liver is the major organ for cholesterol metabolism. Abnormal hepatic cholesterol metabolism not only leads to NAFLD but also drives the development...
2 CitationsSource
Importance null Observational studies suggest that statins, which inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, may be associated with beneficial effects in many noncardiovascular diseases. null Objective null To construct a weighted HMG-CoA reductase (HMGCR) gene genetic risk score (GRS) using variants in the HMGCR gene affecting low-density lipoprotein cholesterol as an instrumental variable for mendelian randomization analyses to test associations with candidate noncardio...